Miningdoctor, I think you have highlighted the problem.
Bluechiip has two board members with Accounting/Commerce qualifications and two with Engineering quals.
Bluechiip’s customers have qualifications in biological sciences, pathology, pharmacology, biochemistry etc and many to PhD levels.
They are two very different groups with little empathy for one another. They certainly would not have a lot to talk about over the dinner table.
- Forums
- ASX - By Stock
- BCT
- Ann: Lodgement of Open Briefing
Ann: Lodgement of Open Briefing, page-19
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BCT (ASX) to my watchlist
|
|||||
Last
0.5¢ |
Change
0.001(11.1%) |
Mkt cap ! $5.910M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $1.5K | 300K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 4628000 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 2032 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 4628000 | 0.004 |
20 | 7000248 | 0.003 |
14 | 8230000 | 0.002 |
2 | 1800000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 2032 | 1 |
0.006 | 3577861 | 6 |
0.007 | 1583539 | 6 |
0.008 | 500000 | 1 |
0.009 | 90000 | 1 |
Last trade - 12.58pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
BCT (ASX) Chart |